Security key
03237H101
Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)
CUSIP: 03237H101
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 1,574
- Total 13F value
- $28,269
- Share change
- +675
- SEC-reported price per share
- $17.96
- Number of holders
- 3
- Value change
- +$12,122
- Number of buys
- 3
- Shares outstanding
- 110,465,093
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
3
Top holders
3
AMLX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Amylyx Pharmaceuticals, Inc. SEC filings
Amylyx Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03237H101
Recent filing periods:
Ownership snapshot
Top reported holders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F
13D/G
Lead comparable stake: 15%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
15%
PERCEPTIVE ADVISORS LLC
7.5%
BlackRock, Inc.
7.1%
TCG Crossover GP II, LLC
5.7%
Commodore Capital LP
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
Company
|
15%
from 13D/G
|
$231,164,520
16,630,541 shares
|
— | 31 Mar 2026 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
7.5%
|
$136,452,007
8,284,882 shares
|
-$10,993,445 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.1%
from 13D/G
|
$122,720,817
8,828,836 shares
|
— | 31 Mar 2026 |
| TCG Crossover GP II, LLC |
13D/G
|
5.7%
|
$74,863,306
6,243,812 shares
|
$0 | 31 Dec 2025 |
| Commodore Capital LP |
13D/G
13F
Company
|
5.1%
|
$89,213,500
5,650,000 shares
|
$0 | 10 Nov 2025 |
| Point72 Asset Management, L.P. |
13D/G
13F
Company
|
2.6%
|
$38,074,233
2,801,636 shares
|
-$26,039,432 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
1,574
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
170
Q2 2026 holders
3
Holder diff
-167
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend